Compare BioNano Genomics Inc (BNGO) vs CVS Health Corp (CVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs CVS Health Corp — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.31M), while CVS Health Corp trades at $93.32 (market cap $122.36B). The key difference: CVS Health Corp is far larger — about 9193.1× BioNano Genomics Inc's market cap, and CVS Health Corp pays a 2.78% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | CVS | |
|---|---|---|
Market Cap | $13.31M | $122.36B |
Sector | Health | Health |
52-Week High | $4.92 | $110.60 |
52-Week Low | $1.06 | $65.51 |
Enterprise Value | $15.92M | $184.71B |
Dividend Yield | — | 2.78% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →
